{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:58:26Z","timestamp":1788922706081,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejogrb.2021.07.046","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:00:23Z","timestamp":1627448423000},"page":"358-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Parvovirus b19 infection in pregnancy \u2013 A review"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-3301","authenticated-orcid":false,"given":"Charles E.","family":"Gigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-3033","authenticated-orcid":false,"given":"Dilly O.C.","family":"Anumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2021.07.046_b0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006254-199704000-00023","article-title":"Infection by parvovirus B19 during pregnancy: a review","volume":"52","author":"Levy","year":"1997","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)65681-7","article-title":"On the confusion of two different diseases under the name rubella (rose-rash)","volume":"156","author":"Dukes","year":"1900","journal-title":"Lancet"},{"issue":"7898","key":"10.1016\/j.ejogrb.2021.07.046_b0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"305","author":"Cossart","year":"1975","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejogrb.2021.07.046_b0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1701-2163(16)30329-2","article-title":"Parvovirus B19 infection in pregnancy","volume":"24","author":"Crane","year":"2002","journal-title":"J Obstet Gynaecol Can."},{"issue":"4","key":"10.1016\/j.ejogrb.2021.07.046_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.siny.2009.01.007","article-title":"Parvovirus B19 infection","volume":"14","author":"Tolfvenstam","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"issue":"8535","key":"10.1016\/j.ejogrb.2021.07.046_b0030","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(87)90370-9","article-title":"Human parvovirus B19 infections in United Kingdom 1984\u201386","volume":"329","author":"Anderson","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.046_b0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1056\/NEJM198507113130203","article-title":"An erythema infectiosum-like illness caused by human parvovirus infection","volume":"313","author":"Plummer","year":"1985","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.046_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/154.3.383","article-title":"The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease)","volume":"154","author":"Chorba","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0029-7844(97)00701-1","article-title":"Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms","volume":"91","author":"Harger","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.07.046_b0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10096-008-0635-y","article-title":"Occupational risk of human cytomegalovirus and parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence","volume":"28","author":"Stelma","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0055","unstructured":"Centers for Disease Control (CDC). Risks associated with human parvovirus B19 infection. MMWR Morb Mortal Wkly Rep 1989;38:81\u20138, 93\u20137."},{"key":"10.1016\/j.ejogrb.2021.07.046_b0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1471-0528.2010.02749.x","article-title":"Parvovirus B19 infection in human pregnancy","volume":"118","author":"Lamont","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1099\/jmm.0.05485-0","article-title":"Advances in the biology, diagnosis and host-pathogen interactions parvovirus B19","volume":"53","author":"Corcoran","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000149587","article-title":"Characteristics and taxonomy of Parvoviridae","volume":"23","author":"Siegl","year":"1985","journal-title":"Intervirology"},{"issue":"4766","key":"10.1016\/j.ejogrb.2021.07.046_b0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1126\/science.3738514","article-title":"Replication of the B19 parvovirus in human bone marrow cell cultures","volume":"233","author":"Ozawa","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0080","doi-asserted-by":"crossref","unstructured":"Saarinen UM, Chorba TL, Tattersall P, Young NS, Anderson LJ, Palmer E, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 1986;67:1411\u20137.","DOI":"10.1182\/blood.V67.5.1411.bloodjournal6751411"},{"issue":"8","key":"10.1016\/j.ejogrb.2021.07.046_b0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00006454-198708000-00003","article-title":"Role of parvovirus B19 in human disease","volume":"6","author":"Anderson","year":"1987","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.07.046_b0090","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI112978","article-title":"Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19)","volume":"79","author":"Potter","year":"1987","journal-title":"J Clin Invest"},{"issue":"8426","key":"10.1016\/j.ejogrb.2021.07.046_b0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","article-title":"Human parvovirus arthropathy","volume":"325","author":"White","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.046_b0100","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3476(05)80677-8","article-title":"Myocarditis caused by parvovirus","volume":"116","author":"Saint-Martin","year":"1990","journal-title":"J Pediatr"},{"issue":"8857","key":"10.1016\/j.ejogrb.2021.07.046_b0105","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/0140-6736(93)90973-K","article-title":"Heart failure after parvovirus B19 infection","volume":"341","author":"Malm","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0110","doi-asserted-by":"crossref","unstructured":"Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990;300:1166\u201370.","DOI":"10.1136\/bmj.300.6733.1166"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.046_b0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","article-title":"Immediate and long term outcome of human parvovirus B19 infection in pregnancy","volume":"105","author":"Miller","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.07.046_b0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pd.2714","article-title":"Parvovirus B19 infection in pregnancy: new insights and management","volume":"31","author":"de Jong","year":"2011","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.07.046_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000236149","article-title":"Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit","volume":"25","author":"Simms","year":"2009","journal-title":"Fetal Diagn Ther"},{"issue":"8534","key":"10.1016\/j.ejogrb.2021.07.046_b0130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(87)90442-9","article-title":"Parvovirus B19 associated with fetal abnormality","volume":"329","author":"Weiland","year":"1987","journal-title":"Lancet"},{"issue":"01","key":"10.1016\/j.ejogrb.2021.07.046_b0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-994201","article-title":"An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases","volume":"13","author":"Katz","year":"1996","journal-title":"Am J Perinatol."},{"issue":"11","key":"10.1016\/j.ejogrb.2021.07.046_b0140","first-page":"1232","article-title":"Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops","volume":"109","author":"Dembinski","year":"2002","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.07.046_b0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.AOG.0000249611.67873.94","article-title":"Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection","volume":"109","author":"Nagel","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(88)91332-3","article-title":"B19 parvovirus infection of myocardial cells","volume":"1","author":"Porter","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.07.046_b0155","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/jcm.33.5.1363-1365.1995","article-title":"Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19","volume":"33","author":"Bruu","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.046_b0160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/jcm.34.3.603-608.1996","article-title":"Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops","volume":"34","author":"Zerbini","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1471-0528.2009.02109.x","article-title":"Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens","volume":"116","author":"Bonvicini","year":"2009","journal-title":"BJOG"},{"issue":"1-2","key":"10.1016\/j.ejogrb.2021.07.046_b0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01379092","article-title":"DNA replication of parvovirus B19 in a human erythroid leukemia cell line (JK-1) in vitro","volume":"131","author":"Takahashi","year":"1993","journal-title":"Arch Virol"},{"issue":"6231","key":"10.1016\/j.ejogrb.2021.07.046_b0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.280.6231.1580","article-title":"Febrile illness due to a parvovirus","volume":"280","author":"Shneerson","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0180","first-page":"59","article-title":"Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy)","volume":"5","author":"Morgan-Capner","year":"2002","journal-title":"Commun Dis Public Health"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.046_b0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJMoa052855","article-title":"Doppler ultrasonography versus amniocentesis to predict fetal anemia","volume":"355","author":"Oepkes","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.046_b0190","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0002-9378(99)70059-1","article-title":"All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid","volume":"180","author":"Skj\u00f6ldebrand-Sparre","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0195","doi-asserted-by":"crossref","unstructured":"Ergaz Z, Ornoy A. Parvovirus B19 in pregnancy, Reprod Toxicol. 2006 May;21(4):421-35.","DOI":"10.1016\/j.reprotox.2005.01.006"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0200","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jama.281.12.1099","article-title":"Risk factors for parvovirus B19 infection in pregnancy","volume":"281","author":"Valeur-Jensen","year":"1999","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.07.046_b0205","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/cis1046","article-title":"Groupe d\u2019experts de l\u2019Assistance Publique-H\u00f4 pitaux de Paris: Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: a retrospective study of 10 patients and review of the literature","volume":"56","author":"Crabol","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2014.11.004","article-title":"Antiviral effect of cidofovir on parvovirus B19 replication","volume":"113","author":"Bonvicini","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2017.03.022","article-title":"Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells","volume":"136","author":"Bonvicini","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"43","key":"10.1016\/j.ejogrb.2021.07.046_b0220","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2011.07.080","article-title":"Safety and immunogenicity of a candidate parvovirus B19 vaccine","volume":"29","author":"Bernstein","year":"2011","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.ejogrb.2021.07.046_b0225","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1016\/j.vaccine.2013.06.062","article-title":"Generation of a parvovirus B19 vaccine candidate","volume":"31","author":"Chandramouli","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.07.046_b0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.046_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.035","article-title":"Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome","volume":"206","author":"De Jong","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.046_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.01.048","article-title":"Fetal thrombocytopenia in pregnancies with fetal human parvovirus-B19 infection","volume":"212","author":"Melamed","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/JPM.2005.100","article-title":"Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin","volume":"33","author":"Matsuda","year":"2005","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0250","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1469-0705.2001.00471.x","article-title":"Fetal parvovirus B19 infection","volume":"18","author":"Von Kaisenberg","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.07.046_b0255","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(95)92346-2","article-title":"Observational study of effect of intrauterine transfusion on outcome of fetal hydrops after parvovirus B19 infection","volume":"346","author":"Fairley","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.07.046_b0260","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9378(98)70203-0","article-title":"Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians","volume":"179","author":"Rodis","year":"1998","journal-title":"Am J Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:56:29Z","timestamp":1759557389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":52,"alternative-id":["S0301211521003900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.07.046","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parvovirus b19 infection in pregnancy \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.07.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}